Conservative treatment has a role in elderly patients with Chronic Limb-Threatening Ischemia, especially in very elderly patients (≥ 85 years).

IF 1.6 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE
Bob T A Schultze, Klaas H J Ultee, Matthijs G Buimer, Hans G W de Groot, Eelco J Veen, Gwan H Ho, Paul G H Mulder, Lijckle van der Laan
{"title":"Conservative treatment has a role in elderly patients with Chronic Limb-Threatening Ischemia, especially in very elderly patients (≥ 85 years).","authors":"Bob T A Schultze, Klaas H J Ultee, Matthijs G Buimer, Hans G W de Groot, Eelco J Veen, Gwan H Ho, Paul G H Mulder, Lijckle van der Laan","doi":"10.1016/j.avsg.2025.09.020","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study primarily aimed to assess mortality and amputation-free survival in elderly patients with chronic limb-threatening ischemia (CLTI) treated with conservative management, open surgical revascularization (OSR) or endovascular revascularization therapy (ERT). The secondary objective was to identify any risk factors associated with mortality in this cohort and to identify which of the survival-related variables are associated with the decision for conservative treatment.</p><p><strong>Design: </strong>A single-centre retrospective cohort study was conducted to evaluate patients aged ≥65 years diagnosed with CLTI for the first time between 2013 and 2020.</p><p><strong>Methods: </strong>Patient demographics, treatment details and outcomes up to 5 years were collected. Overall survival and amputation-free survival were analysed using Kaplan-Meier estimate curves. The estimated effects on survival and amputation-free survival were assessed with a Cox Proportional Hazards regression model.</p><p><strong>Results: </strong>A total of 743 patients were included. Conservative treatment has a role in elderly patients with CLTI and was frequently initiated (30.1%). Conservative treatment resulted in a 1-year survival of 58% and an amputation-free survival of 54%, and a 5-year survival of 14% and an amputation-free survival of 13%. In patients aged ≥85 years conservative treatment had a 1-year survival of 52%, which was a similar trend to the survival of 51% after ERT. Independent associations with mortality were found for age, preoperative haemoglobin, ASA score, Fontaine classification, femoropopliteal TASC, a history of COPD, cardiac disease and CVA, eGFR and postoperative complications (delirium, pneumonia, AMI).</p><p><strong>Conclusion: </strong>This study showed that conservative treatment should be considered as an appropriate treatment option in frail high-risk elderly patients, particularly those with a predicted survival of less than two years. The findings emphasize the significance of integrating patient specific factors into the process of treatment and shared decision making.</p>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of vascular surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.avsg.2025.09.020","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study primarily aimed to assess mortality and amputation-free survival in elderly patients with chronic limb-threatening ischemia (CLTI) treated with conservative management, open surgical revascularization (OSR) or endovascular revascularization therapy (ERT). The secondary objective was to identify any risk factors associated with mortality in this cohort and to identify which of the survival-related variables are associated with the decision for conservative treatment.

Design: A single-centre retrospective cohort study was conducted to evaluate patients aged ≥65 years diagnosed with CLTI for the first time between 2013 and 2020.

Methods: Patient demographics, treatment details and outcomes up to 5 years were collected. Overall survival and amputation-free survival were analysed using Kaplan-Meier estimate curves. The estimated effects on survival and amputation-free survival were assessed with a Cox Proportional Hazards regression model.

Results: A total of 743 patients were included. Conservative treatment has a role in elderly patients with CLTI and was frequently initiated (30.1%). Conservative treatment resulted in a 1-year survival of 58% and an amputation-free survival of 54%, and a 5-year survival of 14% and an amputation-free survival of 13%. In patients aged ≥85 years conservative treatment had a 1-year survival of 52%, which was a similar trend to the survival of 51% after ERT. Independent associations with mortality were found for age, preoperative haemoglobin, ASA score, Fontaine classification, femoropopliteal TASC, a history of COPD, cardiac disease and CVA, eGFR and postoperative complications (delirium, pneumonia, AMI).

Conclusion: This study showed that conservative treatment should be considered as an appropriate treatment option in frail high-risk elderly patients, particularly those with a predicted survival of less than two years. The findings emphasize the significance of integrating patient specific factors into the process of treatment and shared decision making.

保守治疗在老年慢性肢体缺血患者中具有一定的作用,特别是在高龄患者(≥85岁)中。
目的:本研究主要旨在评估老年慢性肢体威胁性缺血(CLTI)患者接受保守治疗、开放手术血运重建术(OSR)或血管内血运重建术(ERT)治疗的死亡率和无截肢生存率。次要目的是确定该队列中与死亡率相关的任何危险因素,并确定哪些与生存相关的变量与保守治疗的决定相关。设计:本研究采用单中心回顾性队列研究,对2013年至2020年间首次诊断为CLTI的年龄≥65岁的患者进行评估。方法:收集患者的人口统计资料、治疗细节和5年的结果。采用Kaplan-Meier估计曲线分析总生存率和无截肢生存率。使用Cox比例风险回归模型评估对生存和无截肢生存的估计影响。结果:共纳入743例患者。保守治疗在老年CLTI患者中起作用,并且经常开始(30.1%)。保守治疗的1年生存率为58%,无截肢生存率为54%,5年生存率为14%,无截肢生存率为13%。在≥85岁的患者中,保守治疗的1年生存率为52%,这与ERT后的51%的生存率趋势相似。年龄、术前血红蛋白、ASA评分、Fontaine分类、股腘动脉TASC、COPD、心脏病和CVA病史、eGFR和术后并发症(谵妄、肺炎、AMI)与死亡率存在独立关联。结论:本研究表明,对于体弱多病的高龄高危患者,特别是那些预计生存期小于2年的患者,保守治疗是一种合适的治疗选择。研究结果强调了将患者特定因素纳入治疗过程和共同决策的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
13.30%
发文量
603
审稿时长
50 days
期刊介绍: Annals of Vascular Surgery, published eight times a year, invites original manuscripts reporting clinical and experimental work in vascular surgery for peer review. Articles may be submitted for the following sections of the journal: Clinical Research (reports of clinical series, new drug or medical device trials) Basic Science Research (new investigations, experimental work) Case Reports (reports on a limited series of patients) General Reviews (scholarly review of the existing literature on a relevant topic) Developments in Endovascular and Endoscopic Surgery Selected Techniques (technical maneuvers) Historical Notes (interesting vignettes from the early days of vascular surgery) Editorials/Correspondence
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信